Increasing Prevalence Of Infectious Diseases Is Driving The Growth Of The Positron Emission Tomography (PET) Radiotracer Market: Transformative Forces Shaping the Positron Emission Tomography (PET) Radiotracer Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Positron Emission Tomography (PET) Radiotracer Industry Market Size Be by 2025?
There has been a significant expansion in the size of the positron emission tomography (PET) radiotracer market in recent years. The market is projected to increase from $2.35 billion in 2024 to $2.57 billion in 2025, showing a compound annual growth rate (CAGR) of 9.3%. This upward trend in the historic period is due to several factors including the rising instances of infectious diseases, increased awareness and accessibility of radiotracers, emergence of innovative radiotracers, a greater occurrence of cancer, and an intensified focus on preventive medicine.

What's the Long-Term Growth Forecast for the Positron Emission Tomography (PET) Radiotracer Market Size Through 2029?
The market size of positron emission tomography (PET) radiotracer is projected to witness significant expansion in the upcoming years, escalating to $3.63 billion in 2029 with a compound annual growth rate (CAGR) of 9.1%. The forecasted growth can be credited to factors like widening of applications, regulatory sanctions, expansion in upcoming markets, an increasing elderly populace, and a higher adoption rate of PET radio scanners. The anticipated trends for the forecast period include the evolution of micro-PET technology, incorporation of wearable technology, growth of theranostics, introduction of nano-radiotracers, and the usage of blockchain for securing data.

View the full report here:
https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

What Are the Key Growth Drivers Fueling the Positron Emission Tomography (PET) Radiotracer Market Expansion?
The rise in infectious diseases is predicted to spur the expansion of the positron emission tomography (PET) radiotracer market. These diseases are caused by harmful microorganisms such as bacteria, viruses, parasites, or fungi. The spread of such diseases has been amplified due to factors like climate change, urbanization, globalization, antibiotic resistance, and shifts in human behavior. PET radiotracers play a crucial role in managing infectious diseases as they allow for visualizing metabolic activity and inflammation, which aids in detecting infections, evaluating treatment responses, and distinguishing between infectious and non-infectious conditions for improved patient outcomes. To illustrate, a report released by the UK Health Security Agency in February 2024 demonstrated that tuberculosis (TB) cases in England rose by 10.7% in 2023, reporting 4,850 cases versus 4,380 in 2022. Hence, the ongoing rise in infectious diseases is fueling the growth of the positron emission tomography (PET) radiotracer market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19152&type=smp

What Are the Key Trends Driving Positron Emission Tomography (PET) Radiotracer Market Growth?
Major firms in the positron emission tomography (PET) radiotracer market are prioritizing the development of advanced diagnostic tools like PET imaging agents, which serve to amplify cancer detection and bolster patient outcomes. A PET imaging agent is a radioactive material used to illustrate and gauge bodily biological processes during PET scans. For example, a Canada-based radiopharmaceutical firm, IsoLogic Innovative Radiopharmaceuticals, launched Illuccix, or the Ga-68 Gozetotide Preparation Kit (PSMA-11), in March 2023. This prostate cancer imaging agent is used in Canada to track metastatic prostate cancer, offering a significant resource for doctors in spotting metastatic disease and facilitating patient treatment decisions. It's recommended for use in patients presumed to have metastases who are suitable for initial definitive therapy, or for those suspected of recurrence due to increased serum prostate-specific antigen (PSA) levels.

How Is the Positron Emission Tomography (PET) Radiotracer Market Segmented?
The positron emission tomography (PET) radiotracer market covered in this report is segmented -

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types
2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:
1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)
2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
3) By Other Radiotracer Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19152&type=smp

Which Companies Are Leading the Charge in Positron Emission Tomography (PET) Radiotracer Market Innovation?
Major companies operating in the positron emission tomography (PET) radiotracer marker are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

Which Regions Are Leading the Global Positron Emission Tomography (PET) Radiotracer Market in Revenue?
North America was the largest region in the positron emission tomography (PET) radiotracer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19152

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.